Detection of differentially expressed HES-6 gene in metastatic colon carcinoma by combination of suppression subtractive hybridization and cDNA library array

Cancer Letters

Volumn 198, Issue 2, 2003, Pages 229-239

  Swearingen, Michelle L ^a   Sun, Duo ^a   Bourner, Maureen ^a   Weinstein, Edward J ^a  

^a PFIZER INC   (United States)

Author keywords

Array; Colorectal carcinoma; HES 6; HT 29; Metastasis; Suppression subtractive hybridization

Indexed keywords

COMPLEMENTARY DNA; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HES6 PROTEIN, HUMAN; HES6 PROTEIN, MOUSE; PRIMER DNA; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CANCER GROWTH; CANCER SCREENING; COLON CARCINOMA; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA LIBRARY; DNA MICROARRAY; GENE; GENE ISOLATION; GENE OVEREXPRESSION; HES 6 GENE; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTASIS; MOLECULAR CLONING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR CELL LINE; VALIDATION PROCESS; ANIMAL; BREAST TUMOR; CELL CULTURE; CHROMOSOME ABERRATION; COLON TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETICS; KIDNEY TUMOR; LUNG TUMOR; METHODOLOGY; MOUSE; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; XENOGRAFT;

ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; COLONIC NEOPLASMS; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0142056091     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00313-6     Document Type: Article

References (44)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer Statistics, 1999, CA. Cancer J. Clin. 49:1999;8-31.
2. McLeod H.L., McKay J.A., Collie-Duguid E.S.R., Cassidy J. Therapeutic opportunities from tumour biology in metastatic colon cancer. Eur. J. Cancer. 36:2000;1706-1712.
3. Parie-McDermott A., McWilliam P., Tighe O., Dunican D., Croke D.T. Serial analysis of gene expression identifies putative metastasis-associated transcripts in colon tumour cell lines. Br. J. Cancer. 83:2002;725-728.
4. Nestl A., Von Stein O.D., Zatloukal K., Theis W.-G., Herrlich P., Hofmann M., et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res. 61:2001;1569-1577.
5. Porkka K.P., Visakorpi T. Detection of differentially expressed genes in prostate cancer by combining suppression subtractive hybridization and cDNA library array. J. Path. 193:2001;73-79.
6. Schumacher U., Adam E., Flavell D.J., Boehm D., Brooks S.A., Leahem A.J. Glycosylation patterns of the human colon cancer cell line HT-29 detected by Helix ponatia agglutinin and other lectins in culture, primary tumours and in metastases in SCID mice. Clin. Exp. Met. 12:1994;398-404.
7. Masferrer J.L., Leahy K.M., Koki A.T., Zweifel B.S., Settle S.L., Woerner B.M., et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 60:2000;1306-1311.
8. Jojovic M., Schumacher U. Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer transplanted into SCID mice. Cancer Lett. 152:2000;151-156.
9. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
10. Peindo M.A., Malkhosyan S., Velazquez A., Perucho M. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc. Natl Acad. Sci. USA. 89:1992;10065-10069.
11. Lin H., Pizer E.S., Morin P.J. A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer. Genomics. 69:2000;391-394.
12. Shridhar V., Sen A., Chien J., Staub J., Avula R., Kovats S., et al. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res. 62:2002;262-270.
13. Stassar M.J.J.G., Devitt G., Brosius M., Rinnab L., Prang J., Schradin T., et al. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. J. Cancer. 85:2001;1372-1382.
14. Zhang Z., DuBois R.N. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene. 20:2001;4450-4456.
15. Weinstein E.J., Bourner M., Head R., Zakeri H., Bauer C., Mazzarella R. URP1: A member of a novel family of PH and ERM domain-containing membrane-associated proteins is significantly over-expressed in lung and colon carcinomas. Biochim. Biophys. Acta. 1637:2003;207-216.
16. Pissarra L., Henrique D., Duarte A. Expression of hes6, a new member of the Hairy/Enhancer-of-split family, in mouse development. Mech. Dev. 95:2000;275-278.
17. Vasiliauskas D., Stern C.D. Expression of mouse HES-6, a new member of the Hairy/Enhancer of split family of bHLH transcription factors. Mech. Dev. 98:2000;133-137.
18. Lee J., Ishimoto A., Honjo T., Yanagawa S. Murine leukemia provirus-mediated activation of the Notch1 gene leads to induction of HES-1 in a mouse T lymphoma cell line, DL-3. FEBS Lett. 455:1999;276-280.
19. Imatani A., Callahan R. Identification of a novel NOTCH-4/INT-3 RNA species encoding and activated gene product in certain human tumor cell lines. Oncogene. 19:2000;223-231.
20. Nam Y., Aster J.C., Blacklow S.C. Notch signaling as a therapeutic target. Curr. Opin. Chem. Biol. 6:2002;501-509.
21. Mitelman F., Johansson B., Mertens F. Mitelman Database of Chromosome Aberrations in Cancer. 2002;. http://cgap.nci.nih.gov/chromosomes/mitelman.
22. Lukeis R., Ball D., Irving L., Garson O.M., Hasthorpe S. Chromosome abnormalitites in non-small cell lung cancer pleural effusions: cytogenic indicators of disease subgroups. Genes Chromosomes Cancer. 8:1993;262-269.
23. Miura I., Siegfried J.M., Resau J., Keller S.M., Zhou J., Testa J.R. Chromosome alterations in 21 non-small cell lung carcinomas. Genes Chromosomes Cancer. 2:1990;328-338.
24. Pejovic T., Heim S., Mandahl N., Elmfors B., Floderus U.M., Furgyik S., et al. Consistent occurrence of the 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarciomas. Genes Chromosomes Cancer. 1:1989;167-171.
25. Pejovic T., Heim S., Mandahl N., Baldetorp B., Elmfors B., Floderus U.M., et al. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer. 4:1992;58-68.
26. Thompson F.H., Emerson J., Alberts D., Liu Y., Guan X.-Y., Burgess A., et al. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet. Cytogenet. 73:1994;33-45.
27. Bernardino J., Apiou F., Gerbault-Seureau M., Malfoy B., Dutrillaux B. Characterization of recurrent homogeneously staining regions in 72 breast carcinomas. Genes Chromosomes Cancer. 23:1998;100-108.
28. Dutrillaux B., Gerbault-Seureau M., Zafrani B. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradipllid cases with few chromosome changes. Genes Chromosomes Cancer. 49:1990;203-217.
29. Steinarsdottir M., Petursdottir I., Snorradottir S., Eyfjord J.E. Cytogenic studies of breast carcinomas: different karyotypic profiles detected by direct harvesting and short term culture. Genes Chromosomes Cancer. 13:1995;239-248.
30. Tan P.H., Lui W.O., Ong P., Lau L.C., Tao M., Chong Y.-Y. Cytogenetic analysis of invasive breast cancer: a study of 27 Asian patients. Genes Chromosomes Cancer. 121:2000;61-66.
31. Thompson F.H., Emerson J., Dalton W., Yang J.-M., McGee D., Villar H., et al. Clonal chromosome abnormalities in human breast carcinomas I. Twenty-eight cases with primary disease. Genes Chromosomes Cancer. 7:1993;185-193.
32. Trent J., Yang J.-M., Emerson J., Dalton W., McGee D., Massey K., et al. Clonal chromosome abnormalities in human breast carcinoma II. Thirty-four cases with metastatic disease. Genes Chromosomes Cancer. 7:1993;194-203.
33. Gunawan B., Huber W., Holtrup M., von Heydebreck A., Efferth T., Poustka A., et al. Prognostic impacts of cytogenic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res. 61:2001;7731-7738.
34. Kovacs G., Frisch S. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res. 49:1989;651-659.
35. Miyasaka Y., Enomoto N., Nagayama K., Izumi N., Marumo F., Watanabe M., et al. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Br. J. Cancer. 85:2001;228-234.
36. Saito A., Fujii G., Sato Y., Gotoh M., Sakamoto M., Toda G., et al. Detection of genes expressed in primary colon cancers by in situ hybridisation: overexpression of RACK 1. Mol. Pathol. 55:2002;34-39.
37. Otsuka M., Kato M., Yoshikawa T., Chen H., Brown E.J., Masuho Y., et al. Differential Expression of the L-Plastin Gene in Human Colorectal Cancer Progression and Metastasis. Biochem. Biophys. Res. Commun. 298:2001;876-881.
38. Bae S.-K., Bessho Y., Hojo M., Kageyama R. The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation. Development. 127:2000;2933-2943.
39. Strom A., Arai N., Leers J., Gustafsson J.-A. The Hairy and Enhancer of Split homologue-1 (HES-1) mediates the proliferative effect of 17 β-estradiol on breast cancer cell lines. Oncogene. 19:2000;5951-5953.
40. Muller P., Kietz S., Gustafsson J.-A., Strom A. The anti-estrogenic effect of All-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expression. J. Biol. Chem. 277:2002;28376-28379.
41. Linnoila R.I., Zhao B., DeMayo J.L., Nelkin B.D., Baylin S.B., DeMayo F.J., et al. Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice. Cancer Res. 60:2000;4005-4009.
42. Sriuranpong V., Borges M.W., Ravi R.K., Arnold D.R., Nelkin B.D., Baylin S.B., et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 61:2001;3200-3205.
43. Sriuranpong V., Borges M.W., Strock C.L., Nakakura E.K., Watkins D.N., Blaumueller C.M., et al. Notch Signaling induces rapid degradation of achaete-scute homolog 1. Mol. Cell. Biol. 22:2002;3129-3139.
44. Chen H., Thiagalingam A., Chopra H., Borges M.W., Feder J.N., Nelkin B.D., et al. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc. Natl Acad. Sci. USA. 94:1997;5355-5360.